This 2015 survey-based study analyzed the prescribing practices of obesity medicine specialists prior to the 2012 approval of new anti-obesity medications. Among the 25% of 1,992 surveyed specialists who responded, many reported using stimulant medications like phentermine at higher doses and for longer durations than recommended. Off-label use of medications
